BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 35812139)

  • 1. A guide to oral vaccination: Highlighting electrospraying as a promising manufacturing technique toward a successful oral vaccine development.
    Aldossary AM; Ekweremadu CSM; Offe IM; Alfassam HA; Han S; Onyali VC; Ozoude CH; Ayeni EA; Nwagwu CS; Halwani AA; Almozain NH; Tawfik EA
    Saudi Pharm J; 2022 Jun; 30(6):655-668. PubMed ID: 35812139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of M cells in infection and mucosal vaccines.
    Wang M; Gao Z; Zhang Z; Pan L; Zhang Y
    Hum Vaccin Immunother; 2014; 10(12):3544-51. PubMed ID: 25483705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of innate immunity by bacterial ligands of toll-like receptors.
    Akhmatova NK; Egorova NB; Kurbatova EA; Akhmatov EA
    Front Immunol; 2014; 5():89. PubMed ID: 24634669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New generation of mucosal adjuvants for the induction of protective immunity.
    Yuki Y; Kiyono H
    Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.
    Yamamoto M; Rennert P; McGhee JR; Kweon MN; Yamamoto S; Dohi T; Otake S; Bluethmann H; Fujihashi K; Kiyono H
    J Immunol; 2000 May; 164(10):5184-91. PubMed ID: 10799877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmonella Uptake into Gut-Associated Lymphoid Tissues: Implications for Targeted Mucosal Vaccine Design and Delivery.
    Richards AF; Torres-Velez FJ; Mantis NJ
    Methods Mol Biol; 2022; 2410():305-324. PubMed ID: 34914054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosa-associated lymphoid tissues in the aerodigestive tract: their shared and divergent traits and their importance to the orchestration of the mucosal immune system.
    Kunisawa J; Fukuyama S; Kiyono H
    Curr Mol Med; 2005 Sep; 5(6):557-72. PubMed ID: 16178767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present Scenario of M-Cell Targeting Ligands for Oral Mucosal Immunization.
    Saraf S; Jain S; Sahoo RN; Mallick S
    Curr Drug Targets; 2020; 21(12):1276-1284. PubMed ID: 32516099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Craniofacial mucosal immune system: importance of its unique organogenesis and function in the development of a mucosal vaccine.
    Okada K; Yamasoba T; Kiyono H
    Adv Otorhinolaryngol; 2011; 72():31-6. PubMed ID: 21865684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses after local administration of IgY loaded-PLGA microspheres in gut-associated lymphoid tissue in pigs.
    Torché AM; Le Dimna M; Le Corre P; Mesplède A; Le Gal S; Cariolet R; Le Potier MF
    Vet Immunol Immunopathol; 2006 Feb; 109(3-4):209-17. PubMed ID: 16219363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mucosal immune system for vaccine development.
    Lamichhane A; Azegamia T; Kiyonoa H
    Vaccine; 2014 Nov; 32(49):6711-23. PubMed ID: 25454857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anatomy of mucosal immune responses.
    Garside P; Millington O; Smith KM
    Ann N Y Acad Sci; 2004 Dec; 1029():9-15. PubMed ID: 15681738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination.
    De Smet R; Demoor T; Verschuere S; Dullaers M; Ostroff GR; Leclercq G; Allais L; Pilette C; Dierendonck M; De Geest BG; Cuvelier CA
    J Control Release; 2013 Dec; 172(3):671-8. PubMed ID: 24041710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches.
    Spahn TW; Fontana A; Faria AM; Slavin AJ; Eugster HP; Zhang X; Koni PA; Ruddle NH; Flavell RA; Rennert PD; Weiner HL
    Eur J Immunol; 2001 Apr; 31(4):1278-87. PubMed ID: 11298355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocoa and cocoa fibre differentially modulate IgA and IgM production at mucosal sites.
    Massot-Cladera M; Franch À; Pérez-Cano FJ; Castell M
    Br J Nutr; 2016 May; 115(9):1539-46. PubMed ID: 26975903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic administration of RANKL overcomes the bottleneck of oral vaccine delivery through microfold cells in ileum.
    Maharjan S; Singh B; Jiang T; Yoon SY; Li HS; Kim G; Gu MJ; Kim SJ; Park OJ; Han SH; Kang SK; Yun CH; Choi YJ; Cho CS
    Biomaterials; 2016 Apr; 84():286-300. PubMed ID: 26851393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-thinking the functions of IgA(+) plasma cells.
    Gommerman JL; Rojas OL; Fritz JH
    Gut Microbes; 2014; 5(5):652-62. PubMed ID: 25483334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uniqueness of the mucosal immune system for the development of prospective mucosal vaccine].
    Kunisawa J; Gohda M; Kiyono H
    Yakugaku Zasshi; 2007 Feb; 127(2):319-26. PubMed ID: 17268152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional differences between putative mucosal inductive sites of the rat.
    Zuercher AW; Cebra JJ
    Eur J Immunol; 2002 Nov; 32(11):3191-6. PubMed ID: 12555664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C5a receptor-targeting ligand-mediated delivery of dengue virus antigen to M cells evokes antigen-specific systemic and mucosal immune responses in oral immunization.
    Kim SH; Yang IY; Jang SH; Kim J; Truong TT; Van Pham T; Truong NU; Lee KY; Jang YS
    Microbes Infect; 2013 Nov; 15(13):895-902. PubMed ID: 23892099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.